Literature DB >> 11374848

The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease.

D J Maron1.   

Abstract

Low levels of high-density lipoprotein cholesterol (HDL-C), and elevated total cholesterol-to-HDL-C ratios are independently associated with increased risk of coronary artery disease. In observational studies, every 1-mg/dL increment in HDL-C is associated with a 2% decreased risk of coronary artery disease in men and 3% decreased risk in women. On average, HDL-C levels are lower in men than in women, and are lower in whites than in blacks. Low HDL-C has also been found to be linked to higher risk of ischemic stroke, degree of carotid atherosclerosis, increased atherosclerotic progression as measured by coronary arteriography, higher coronary mortality among people with cardiovascular disease, and the development of coronary artery disease among patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11374848     DOI: 10.1016/s0002-9149(00)01462-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

Review 1.  Reverse cholesterol transport: high-density lipoprotein's magnificent mile.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 2.  High-density lipoprotein subfractions and risk of coronary artery disease.

Authors:  John Morgan; Christina Carey; Anne Lincoff; David Capuzzi
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

3.  High-intensity aerobic interval training improves aerobic fitness and HbA1c among persons diagnosed with type 2 diabetes.

Authors:  Eva Maria Støa; Sondre Meling; Lill-Katrin Nyhus; Karl Magnus Mangerud; Jan Helgerud; Solfrid Bratland-Sanda; Øyvind Støren
Journal:  Eur J Appl Physiol       Date:  2017-02-03       Impact factor: 3.078

4.  Testosterone and the metabolic syndrome.

Authors:  Vakkat Muraleedharan; T Hugh Jones
Journal:  Ther Adv Endocrinol Metab       Date:  2010-10       Impact factor: 3.565

5.  HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells.

Authors:  Fatiha Tabet; Kasey C Vickers; Luisa F Cuesta Torres; Carrie B Wiese; Bassem M Shoucri; Gilles Lambert; Claire Catherinet; Leonel Prado-Lourenco; Michael G Levin; Seth Thacker; Praveen Sethupathy; Philip J Barter; Alan T Remaley; Kerry-Anne Rye
Journal:  Nat Commun       Date:  2014-02-28       Impact factor: 14.919

6.  High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan Study.

Authors:  Eduard Tiozzo; Hannah Gardener; Barry I Hudson; Chuanhui Dong; David Della-Morte; Milita Crisby; Ronald B Goldberg; Mitchell S V Elkind; Ying Kuen Cheung; Clinton B Wright; Ralph L Sacco; Tatjana Rundek
Journal:  Atherosclerosis       Date:  2014-09-09       Impact factor: 5.162

7.  Effects of SNVs in ABCA1, ABCG1, ABCG5, ABCG8, and SCARB1 Genes on Plasma Lipids, Lipoproteins, and Adiposity Markers in a Brazilian Population.

Authors:  Vanessa Helena Souza Zago; Daniel Zanetti Scherrer; Eliane Soler Parra; Isabela Calanca Vieira; Fernando Augusto Lima Marson; Eliana Cotta de Faria
Journal:  Biochem Genet       Date:  2021-09-09       Impact factor: 1.890

8.  Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia.

Authors:  Genovefa D Kolovou; Katherine Anagnostopoulou; Nektarios D Pilatis; Klelia D Salpea; Ioannis S Hoursalas; Ilias Petropoulos; Helen I Bilianou; Dennis V Cokkinos
Journal:  Vasc Health Risk Manag       Date:  2005

9.  Low HDL-C level is associated with the development of intracranial artery stenosis: analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) study.

Authors:  Yining Qian; Yuehua Pu; Liping Liu; David Z Wang; Xingquan Zhao; Chunxue Wang; Yilong Wang; Gaifen Liu; Yuesong Pan; Yongjun Wang
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

Review 10.  Statins in cardiometabolic disease: what makes pitavastatin different?

Authors:  Henry Ginsberg
Journal:  Cardiovasc Diabetol       Date:  2013-05-30       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.